Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical TrialsBlockchain technology has the potential to improve trust, transparency, patient safety and patient empowerment in clinical trials
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news